Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Conant Optical CoHKSE:02276 -5.46%78 Current Ratio is 3.59 as of Dec. 2025, which is 47% above its 10-year median of 2.44. GuruFocus rates HKSE:02276 with a GF Score™ of 78/100 and a GF Value™ of HK$15.68 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Shanghai Conant Optical Co ranks better than 65.8% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Shanghai Conant Optical Co's current ratio for the quarter that ended in Dec. 2025 was 3.59.
Shanghai Conant Optical Co has a current ratio of 3.59. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Shanghai Conant Optical Co's Current Ratio or its related term are showing as below:
HKSE:02276'
s Current Ratio Range Over the Past 10 Years
Min: 0.84 Med: 2.44 Max: 3.59
Current: 3.33
During the past 8 years, Shanghai Conant Optical Co's highest Current Ratio was 3.59. The lowest was 0.84. And the median was 2.44.
HKSE:02276's Current Ratio is ranked better than 65.8% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 2.46
vs HKSE:02276: 3.33
Shanghai Conant Optical Co (HKSE:02276) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Shanghai Conant Optical Co Current Ratio Related Terms
Shanghai Conant Optical Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02276 vs ISRG, BDX, MDLN: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Conant Optical Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Conant Optical Co Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Conant Optical Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai Conant Optical Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Conant Optical Co (HKSE:02276) has a Current Ratio of 3.59 as of Dec. 2025. This is 47% above median its historical median of 2.44. Over the past decade, Shanghai Conant Optical Co's Current Ratio has ranged from 0.84 to 3.59. According to the industry distribution chart, Shanghai Conant Optical Co ranks #291 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 34.2%.
Is Shanghai Conant Optical Co's Current Ratio too high?
Shanghai Conant Optical Co's current Current Ratio of 3.59 is 47% above median its 10-year median of 2.44. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 3.59. The Medical Devices & Instruments industry median Current Ratio is 2.46. Shanghai Conant Optical Co's value of 3.59 is 45.9% above this industry median. Based on the distribution chart, Shanghai Conant Optical Co ranks #291 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shanghai Conant Optical Co has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Conant Optical Co's Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Conant Optical Co ranks #291 out of 851 companies for Current Ratio. This puts Shanghai Conant Optical Co in the upper half of its industry. The industry median Current Ratio is 2.46. Shanghai Conant Optical Co's value of 3.59 is 45.9% above this benchmark. Historically, Shanghai Conant Optical Co's own Current Ratio has ranged from 0.84 to 3.59 over the past decade. While the company's 10-year median is 2.44 vs. the industry median of 2.46, Shanghai Conant Optical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.46, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Conant Optical Co's current Current Ratio of 3.59 is 45.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Conant Optical Co's current Current Ratio is 3.59, which is 47% above median its own 10-year median of 2.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Conant Optical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Conant Optical Co (HKSE:02276) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$15.68, compared to a current price of HK$38.44 — trading 145.2% above its estimated fair value. The current Current Ratio is 3.59, which is 47% above median its 10-year median of 2.44 and 45.9% above the Medical Devices & Instruments industry median of 2.46. Shanghai Conant Optical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Shanghai Conant Optical Co (HKSE:02276), the current Current Ratio is 3.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Conant Optical Co (HKSE:02276) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Conant Optical Co stock appears to be overvalued.
The current stock price of HK$38.44 is trading 145.2% above its estimated GF Value™ of HK$15.68.
GuruFocus considers Shanghai Conant Optical Co to be Significantly Overvalued.
Key valuation signals for HKSE:02276:
Current Ratio: 3.59 (47% above median its 10-year median of 2.44)
GF Value™: HK$15.68 vs. price of HK$38.44 (145.2% above fair value)
Industry Position: 45.9% above the Medical Devices & Instruments median (#291 of 851)
No single metric tells the full story. See the HKSE:02276 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 1-42, Lane 83, Hongxiang North Road, 4th Floor, Building 35, Lin-gang Special Area, China (Shanghai) Pilot Free Trade Zone China, Shanghai, CHN
Shanghai Conant Optical Co Ltd is a resin spectacle lens manufacturer in China. The company offers a wide range of resin spectacle lenses to its customers including standardized lenses and customized lenses. The spectacle lenses are also tinted, coated, or cast with various films or coatings for added functionality, such as polarised, photochromic, blue-ray blocking, anti-scratch, anti-reflection, and anti-smudge. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the Americas, Europe, Oceania, Africa, and Asia (except for mainland China). It products include: CR-Freeform; CoMax; AC lens; Gaming Glassed, Antifog Lens; MyoEase; Polycarbonate lens; Photochromic coating lens; SingleVision Finished Lens; and Others.
78GF Score
Get the complete analysis for HKSE:02276
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02276 has been successfully added to your 
